Traws Pharma earnings were -$54.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TRAW earnings report on Dec 31, 2024 announced Q4 2024 earnings of $81.9M, down 1,066.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TRAW reported annual earnings of -$54.7M, with 188.5% growth.
On TRAW's earnings call on Invalid Date, Traws Pharma (NASDAQ: TRAW) reported Q4 2024 earnings per share (EPS) of $95.66, up 2,020.88% year over year. Total TRAW earnings for the quarter were $81.93 million. In the same quarter last year, Traws Pharma's earnings per share (EPS) was -$4.98.
As of the last Traws Pharma earnings report, Traws Pharma is currently losing money. Traws Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$54.67 million, a 188.55% increase year over year.
What was TRAW's earnings growth in the past year?
As of Traws Pharma's earnings date in Invalid Date, Traws Pharma's earnings has grown year over year. TRAW earnings in the past year totalled -$54.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.